garetosmab trevogrumab semaglutide and and COURAGE Trial confirms potential to improve the quality of semaglutide-induced weight loss by preserving lean mass Are myostatin inhibitors the end – Biotech Watchlist: Trevogrumab, A New

A breastfeeding meta-analysis found lower postpartum weight retention overall in breastfeeding mothers, and breastfeeding can make any medication decision more careful, especially early on

Focus on Hydration Dehydration is a common but avoidable side effect

The higher end of this range is better for anyone doing resistance training, anyone over 50, or anyone who has already lost significant weight

Novartis is investing in expanding Pluvicto's label into pre-taxane prostate cancer (SPLASH trial submission pending), and developing next-generation RLT approaches targeting breast cancer and other tumour types positioning it to maintain leadership in the highest-growth oncology peptide segment

Sunscreen helps prevent some signs of aging in the skin